Some good info here - RGS is hoping to get a licensing deal by the end of this calendar year, and is looking to do a phase 2 trial in the U,S in addition to Japan - something I had not heard before. In addition, Progenza may have disease modifying properties, which in generating interest from potential partners.
http://regeneus.com.au/media/news/JapanChemicalDailyArticle-August2017.pdf
Some info on Licensing deals
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
